Dyslipidemia in granuloma annulare: A case-control study

Archives of Dermatology

Volumn 148, Issue 10, 2012, Pages 1131-1136

  Wu, Wesley ^a   Robinson Bostom, Leslie ^a   Kokkotou, Efi ^b   Jung, Hye Young ^a   Kroumpouzos, George ^a,c  

^a BROWN UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c South Shore Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE MARKER; DYSLIPIDEMIA; FEMALE; GRANULOMA ANNULARE; HISTOPATHOLOGY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; HYPOTHYROIDISM; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; PRIORITY JOURNAL; SKIN DEFECT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHOLESTEROL; CHOLESTEROL, LDL; COMORBIDITY; CONFIDENCE INTERVALS; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; FEMALE; GRANULOMA ANNULARE; HUMANS; HYPERTENSION; HYPOTHYROIDISM; MALE; METABOLIC SYNDROME X; MIDDLE AGED; ODDS RATIO; PREVALENCE; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TRIGLYCERIDES; YOUNG ADULT;

EID: 84867643985     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2012.1381     Document Type: Article

References (48)

1. Studer EM, Calza AM, Saurat JH. Precipitating factors and associated diseases in 84 patients with granuloma annulare: a retrospective study. Dermatology. 1996;193(4):364-368. (Pubitemid 27007592)
2. Tan HH, Goh CL. Granuloma annulare: a review of 41 cases at the National Skin Centre. Ann Acad Med Singapore. 2000;29(6):714-718. (Pubitemid 33710667)
3. Dabski K, Winkelmann RK. Generalized granuloma annulare: clinical and laboratory findings in 100 patients. J Am Acad Dermatol. 1989;20(1):39-47. (Pubitemid 19033844)
4. Magro CM, Crowson AN, Regauer S. Granuloma annulare and necrobiosis lipoidica tissue reactions as a manifestation of systemic disease. Hum Pathol. 1996;27(1):50-56. (Pubitemid 26015580)
5. Hanauer DA, Rhodes DR, Chinnaiyan AM. Exploring clinical associations using "-omics" based enrichment analyses. PLoS One. 2009;4(4):e5203. doi:10.1371/journal.pone.0005203.
6. Muhlemann MF, Williams DR. Localized granuloma annulare is associated with insulin-dependent diabetes mellitus. Br J Dermatol. 1984;111(3):325-329. (Pubitemid 14027436)
7. Nebesio CL, Lewis C, Chuang T-Y. Lack of an association between granuloma annulare and type 2 diabetes mellitus. Br J Dermatol. 2002;146(1):122-124. (Pubitemid 34158420)
8. Dahl MV. Granuloma annulare: long-term follow-up. Arch Dermatol. 2007;143(7):946-947.
9. Crosby DL, Woodley DT, Leonard DD. Concomitant granuloma annulare and necrobiosis lipoidica: report of a case and review of the literature. Dermatologica. 1991;183(3):225-229.
10. Cohen IJ. Necrobiosis lipoidica and granuloma annulare. J Am Acad Dermatol. 1984;10(1):123-124.
11. Davison JE, Davies A, Moss C, Kirk JMW, Taibjee SM, Agwu JC. Links between granuloma annulare, necrobiosis lipoidica diabeticorum and childhood diabetes: a matter of time? Pediatr Dermatol. 2010;27(2):178-181.
12. Dabski K, Winkelmann RK. Generalized granuloma annulare: histopathology and immunopathology: systematic review of 100 cases and comparison with localized granuloma annulare. J Am Acad Dermatol. 1989;20(1):28-39. (Pubitemid 19033843)
13. Fagundes PP, Pinto AS, Pinto PA, Tebcherani AJ, Valente NY. Eruptive xanthoma with unexpected granuloma annulare-like microscopic appearance: case report. An Bras Dermatol. 2009;84(3):289-292.
14. Cooper PH. Eruptive xanthoma: a microscopic simulant of granuloma annulare. J Cutan Pathol. 1986;13(3):207-215. (Pubitemid 16090860)
15. Mempel M, Musette P, Flageul B, et al. T-cell receptor repertoire and cytokine pattern in granuloma annulare: defining a particular type of cutaneous granulomatous inflammation. J Invest Dermatol. 2002;118(6):957-966. (Pubitemid 34639173)
16. Fayyazi A, Schweyer S, Eichmeyer B, et al. Expression of IFNγ, coexpression of TNFα and matrix metalloproteinases and apoptosis of T lymphocytes and macrophages in granuloma annulare. Arch Dermatol Res. 2000;292(8):384-390. (Pubitemid 30618104)
17. Dreiher J, Shapiro J, Cohen AD. Lichen planus and dyslipidaemia: a case-control study. Br J Dermatol. 2009;161(3):626-629.
18. Dreiher J, Weitzman D, Davidovici B, Shapiro J, Cohen AD. Psoriasis and dyslipidaemia: a population-based study. Acta Derm Venereol. 2008;88(6):561-565.
19. Shigehara K, Shijubo N, Ohmichi M, et al. Increased levels of interleukin-18 in patients with pulmonary sarcoidosis. Am J Respir Crit Care Med. 2000;162(5):1979-1982.
20. Baughman RP, Iannuzzi M. Tumour necrosis factor in sarcoidosis and its potential for targeted therapy. BioDrugs. 2003;17(6):425-431. (Pubitemid 37500758)
21. Salazar A, Maña J, Fiol C, et al. Influence of serum amyloid A on the decrease of high density lipoprotein-cholesterol in active sarcoidosis. Atherosclerosis. 2000;152(2):497-502.
22. Arias-Santiago S, Buendía-Eisman A, Aneiros-Fernández J, et al. Lipid levels in patients with lichen planus: a case-control study. J Eur Acad Dermatol Venereol. 2011;25(12):1398-1401. doi:10.1111/j.1468-3083.2011. 03983.
23. Cyr PR. Diagnosis and management of granuloma annulare. Am Fam Physician. 2006;74(10):1729-1734. (Pubitemid 44785740)
24. Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications: part 1: diagnosis and classification of diabetes mellitus: provisional report of a WHO consultation. Diabet Med. 1998;15(7):539-553. (Pubitemid 28319935)
25. Lien LF, Guyton JR. Metabolic syndrome. Dermatol Ther. 2008;21(5):362-375.
26. Magro CM, Crowson AN, Schapiro BL. The interstitial granulomatous drug reaction: a distinctive clinical and pathological entity. J Cutan Pathol. 1998;25(2):72-78. (Pubitemid 28073644)
27. Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol. 2006;55(5):829-835. (Pubitemid 44556851)
28. Fonseca VA. Effects of β-blockers on glucose and lipid metabolism. Curr Med Res Opin. 2010;26(3):615-629.
29. Neves C, Alves M, Medina JL, Delgado JL. Thyroid diseases, dyslipidemia and cardiovascular pathology. Rev Port Cardiol. 2008;27(10):1211-1236.
30. Lee SH, Kwon JE, Lee KG, Roh MR. Granulomatous variant of chronic pigmented purpuric dermatosis associated with hyperlipidaemia. J Eur Acad Dermatol Venereol. 2010;24(10):1243-1245.
31. Lin WL, Kuo TT, Shih PY, Lin WC, Wong WR, Hong HS. Granulomatous variant of chronic pigmented purpuric dermatoses: report of four new cases and an association with hyperlipidaemia. Clin Exp Dermatol. 2007;32(5):513-515.
32. Khovidhunkit W, Kim MS, Memon RA, et al. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res. 2004;45(7):1169-1196. (Pubitemid 38802622)
33. Esteve E, Ricart W, Fernández-Real JM. Dyslipidemia and inflammation: an evolutionary conserved mechanism. Clin Nutr. 2005;24(1):16-31.
34. Ghazizadeh R, Tosa M, Ghazizadeh M. Clinical improvement in psoriasis with treatment of associated hyperlipidemia. Am J Med Sci. 2011;341(5):394-398.
35. Wakkee M, Thio HB, Prens EP, Sijbrands EJ, Neumann HA. Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients. Atherosclerosis. 2007;190(1):1-9. (Pubitemid 44908334)
36. Haroon M, Devlin J. Marked hypertriglyceridemia upon treatment with etanercept. Joint Bone Spine. 2009;76(5):570-571.
37. Ahmed AA, Nordlind K, Schultzberg M, Lidén S. Interleukin-1 alpha- and beta-, interleukin-6- and tumour necrosis factor-alpha-like immunoreactivities in chronic granulomatous skin conditions. Acta Derm Venereol. 1994;74(6):435-440.
38. Murdaca G, Colombo BM, Barabino G, Caiti M, Cagnati P, Puppo F. Anti-tumor necrosis factor-α treatment with infliximab for disseminated granuloma annulare. Am J Clin Dermatol. 2010;11(6):437-439. doi:10.2165/ 11311040-000000000-00000.
39. Werchau S, Enk A, Hartmann M. Generalized interstitial granuloma annulare - response to adalimumab. Int J Dermatol. 2010;49(4):457-460.
40. Voulgari PV, Markatseli TE, Exarchou SA, Zioga A, Drosos AA. Granuloma annulare induced by anti-tumour necrosis factor therapy. Ann Rheum Dis. 2008;67(4):567-570. (Pubitemid 351498443)
41. Rossi M, Carpi A, Di Maria C, Franzoni F, Galetta F, Santoro G. Skin blood flow-motion and microvascular reactivity investigation in hypercholesterolemic patients without clinically manifest arterial diseases. Physiol Res. 2009;58(1):39-47.
42. Stokes KY, Cooper D, Tailor A, Granger DN. Hypercholesterolemia promotes inflammation and microvascular dysfunction: role of nitric oxide and superoxide. Free Radic Biol Med. 2002;33(8):1026-1036.
43. Dahl MV, Ullman S, Goltz RW. Vasculitis in granuloma annulare: histopathology and direct immunofluorescence. Arch Dermatol. 1977;113(4):463-467. (Pubitemid 8071606)
44. Koh MS, Majewski BBJ, Barter S, Chilvers C, Rhodes EL. Serum β-glucuronidase activity in human diabetes mellitus, granuloma annulare and necrobiosis lipoidica. Clin Exp Dermatol. 1983;8(3):299-304. (Pubitemid 13084664)
45. Friedman-Birnbaum R, Ludatscher RM. Comparative ultrastructural study of generalized and localized granuloma annulare. Am J Dermatopathol. 1986;8(4):302-308.
46. Tekin NS, Tekin IO, Barut F, Sipahi EY. Accumulation of oxidized low-density lipoprotein in psoriatic skin and changes of plasma lipid levels in psoriatic patients. Mediators Inflamm. 2007;2007:78454. doi:10.1155/2007/78454.
47. Frostegård J, Wu R, Giscombe R, Holm G, Lefvert AK, Nilsson J. Induction of T-cell activation by oxidized low density lipoprotein. Arterioscler Thromb. 1992;12(4):461-467.
48. Kim J, Chu SK, Kim K, Moon JR. Alcohol use behaviors and risk of metabolic syndrome in South Korean middle-aged men. BMC Public Health. 2011;11:489. doi:10.1186/1471-2458-11-489.